Akzo Nobel N V ADR (AKZOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,983,304 | 2,988,786 | 2,852,024 | 2,675,022 | 2,882,606 |
| Cost of Goods | 1,762,120 | 1,782,804 | 1,797,945 | 1,726,987 | 1,897,565 |
| Gross Profit | 1,221,185 | 1,205,982 | 1,054,079 | 948,035 | 985,042 |
| Operating Expenses | 836,011 | 902,565 | 859,665 | 850,793 | 816,397 |
| Operating Income | 385,294 | 304,222 | 195,359 | 98,228 | 169,210 |
| Interest Expense | 74,011 | 49,068 | 40,789 | 54,145 | 33,238 |
| Other Income | 8,707 | 5,452 | 7,514 | -1,377 | 6,043 |
| Pre-tax Income | 319,990 | 260,606 | 162,083 | 42,706 | 142,015 |
| Income Tax | 104,486 | 115,582 | 48,303 | 33,225 | 51,367 |
| Net Income Continuous | 215,503 | 145,023 | 113,780 | 9,481 | 90,648 |
| Net Income Discontinuous | -1,088 | N/A | -1,073 | -122 | -4,029 |
| Minority Interests | 8,707 | 16,356 | 11,807 | 8,720 | 2,014 |
| Net Income | $205,708 | $128,667 | $100,900 | $638 | $84,605 |
| EPS Basic Total Ops | 0.40 | 0.25 | 0.20 | 0.01 | 0.16 |
| EPS Basic Continuous Ops | 0.42 | 0.28 | 0.22 | 0.03 | 0.17 |
| EPS Basic Discontinuous Ops | 0.00 | N/A | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.40 | 0.25 | 0.20 | 0.01 | 0.16 |
| EPS Diluted Continuous Ops | 0.42 | 0.28 | 0.22 | 0.03 | 0.17 |
| EPS Diluted Discontinuous Ops | 0.00 | N/A | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $481,811 | $401,656 | $288,744 | $210,988 | $256,876 |